We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Squeaky wheel gets the oil

21 December 2017 By Lauren Silva Laughlin

SandRidge adopted a poison pill to fend off investors unhappy with a recent deal. Hess faces another fight with Elliott. Exxon is only now allowing owners to talk to the board. The shareholder pushback is welcome, but the industry’s slow response leaves it exposed to other risks.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)